Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events.

[1]  J. Kaski,et al.  Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. , 2005, European heart journal.

[2]  C. Heeschen,et al.  Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. , 2005, Journal of the American College of Cardiology.

[3]  Elena Bonanno,et al.  Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. , 2004, JAMA.

[4]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[5]  Antonio Colombo,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. , 2003, Circulation.

[6]  P. Giral,et al.  Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. , 2003, Atherosclerosis.

[7]  P. Giral,et al.  Serum Plasma Pregnancy-Associated Protein A: A Potential Marker of Echogenic Carotid Atherosclerotic Plaques in Asymptomatic Hyperlipidemic Subjects at High Cardiovascular Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[8]  R. Gaiser.  Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes , 2002 .

[9]  A. Naylor,et al.  Matrix metalloproteinases and atherosclerotic plaque instability , 2002, The British journal of surgery.

[10]  B. Lal,et al.  Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. , 2002, Journal of vascular surgery.

[11]  I. Loftus,et al.  The role of matrix metalloproteinases in vascular disease , 2002, Vascular medicine.

[12]  R. Virmani,et al.  Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary Death: Association With Different Pathologies , 2002, Circulation.

[13]  G. D. De Meyer,et al.  In Vivo Temperature Heterogeneity of Atherosclerotic Plaques Is Determined by Plaque Composition , 2002, Circulation.

[14]  C. Conover,et al.  Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: identification of a novel inducible inhibitor. , 2002, Endocrinology.

[15]  P. Gorelick.  Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review , 2002, Stroke.

[16]  R. Frink.  Chronic Ulcerated Plaques , 2002 .

[17]  P. Giral,et al.  Elevated C-Reactive Protein Constitutes an Independent Predictor of Advanced Carotid Plaques in Dyslipidemic Subjects , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[19]  P. Ridker,et al.  Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[20]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[21]  M. Overgaard,et al.  Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid. , 2000, Clinical chemistry.

[22]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[23]  R. Virmani,et al.  Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. , 2000, Circulation.

[24]  A. Bayés‐Genís,et al.  The insulin-like growth factor axis: A review of atherosclerosis and restenosis. , 2000, Circulation research.

[25]  R. Frye,et al.  Perturbation of the T-cell repertoire in patients with unstable angina. , 1999, Circulation.

[26]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[27]  V. Fuster,et al.  The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[28]  G Pasterkamp,et al.  Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[29]  D. O'leary,et al.  Asymptomatic internal carotid artery stenosis defined by ultrasound and the risk of subsequent stroke in the elderly. The Cardiovascular Health Study. , 1998, Stroke.

[30]  H. Steinmetz,et al.  Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. , 1998, Stroke.

[31]  J. Slattery,et al.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) , 1998, The Lancet.

[32]  W. Pearce,et al.  Carotid plaque morphology correlates with presenting symptomatology. , 1998, Journal of vascular surgery.

[33]  B. No̸rgaard-Pedersen,et al.  Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. , 1997, Clinical chemistry.

[34]  R. Virmani,et al.  Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. , 1997, Surgery.

[35]  C von Birgelen,et al.  Intravascular elastography: principles and potentials. , 1997, Seminars in interventional cardiology : SIIC.

[36]  J. Boyle,et al.  ASSOCIATION OF CORONARY PLAQUE RUPTURE AND ATHEROSCLEROTIC INFLAMMATION , 1997, The Journal of pathology.

[37]  M. Ferguson,et al.  Carotid plaque morphology and clinical events. , 1997, Stroke.

[38]  G. Bearman,et al.  Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis , 1996, The Lancet.

[39]  R. Virmani,et al.  Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. , 1996, Journal of vascular surgery.

[40]  C. Alpers,et al.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.

[41]  S. Seiden,et al.  Endarterectomy for asymptomatic carotid artery stenosis. , 1995, JAMA.

[42]  A. Davies,et al.  Endarterectomy for asymptomatic carotid artery stenosis , 1995, BMJ.

[43]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[44]  L. Jäncke,et al.  Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. , 1995, Stroke.

[45]  J. Seeger,et al.  The relationship between carotid plaque composition, plaque morphology, and neurologic symptoms. , 1995, The Journal of surgical research.

[46]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[47]  Frink Rj.  Chronic ulcerated plaques: new insights into the pathogenesis of acute coronary disease. , 1994 .

[48]  R. Frink.  Chronic ulcerated plaques: new insights into the pathogenesis of acute coronary disease. , 1994, The Journal of invasive cardiology.

[49]  J. Albers,et al.  Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.

[50]  W S Moore,et al.  Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. , 1993, The New England journal of medicine.

[51]  A. Buchan,et al.  *North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering Committee. Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis. , 1991 .

[52]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[53]  E. Leen,et al.  Histologic characteristics of carotid artery plaque. , 1991, Journal of vascular surgery.

[54]  C. Zarins,et al.  Critical carotid stenoses: morphologic and chemical similarity between symptomatic and asymptomatic plaques. , 1989, Journal of vascular surgery.

[55]  P A Schneider,et al.  Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. , 1988, Stroke.

[56]  FRCP W. J. MacLennan MD,et al.  The Elderly , 1984, Treatment in Clinical Medicine.